Is Booking Holdings Stock Undervalued?
There is a lot of humdrum in the market about…
Buy
61
HVRRY Quote, Financials, Valuation and Earnings
Last price:
$42.20
Seasonality move
:
4.63%
Day range:
$41.49 - $41.62
52-week range:
$38.40 - $48.42
Dividend yield:
2.6%
P/E ratio:
12.30x
P/S ratio:
12.88x
P/B ratio:
2.42x
Volume:
3.8K
Avg. volume:
5.2K
1-year change:
4.25%
Market cap:
$30.1B
Revenue:
$1.2B
EPS (TTM):
$3.38
Analysts' Opinion
-
Consensus RatingHannover Rueck SE has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Hannover Rueck SE has an estimated downside of -- from its current price of $41.55.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $41.55.
Fair Value
-
According to the consensus of 0 analysts, Hannover Rueck SE has -- downside to fair value with a price target of -- per share.
HVRRY vs. S&P 500
-
Over the past 5 trading days, Hannover Rueck SE has overperformed the S&P 500 by 0.47% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Hannover Rueck SE does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Hannover Rueck SE revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Hannover Rueck SE reported revenues of $6.3B.
Earnings Growth
-
Hannover Rueck SE has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Hannover Rueck SE reported earnings per share of $1.01.
Enterprise value:
-30.6B
EV / Invested capital:
--
Price / LTM sales:
12.88x
EV / EBIT:
-10.73x
EV / Revenue:
-13.11x
PEG ratio (5yr expected):
0.11x
EV / Free cash flow:
-4.66x
Price / Operating cash flow:
4.58x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
3.33%
Net Income Margin (TTM):
82.53%
Return On Equity:
19.8%
Return On Invested Capital:
18.24%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $29.7B | $88.1M | $2.3B | $6.6B | $6.3B | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $2.25 | $1.62 | $3.38 | $0.66 | $1.01 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $57.7B | $65.6B | $60B | $54.1B | $63.4B | |
| Total Assets | $85.5B | $94.9B | $89.6B | $68.4B | $78.5B | |
| Current Liabilities | $2.6B | $3B | $3.3B | $278.3M | $526.4M | |
| Total Liabilities | $71.8B | $80.6B | $80.9B | $57.3B | $65.1B | |
| Total Equity | $13.7B | $14.2B | $8.8B | $11.1B | $13.4B | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $4.5B | $6B | $6.6B | $1.4B | $1.9B | |
| Cash From Investing | -$4.1B | -$5.6B | -$4.9B | -$1.5B | -$1.2B | |
| Cash From Financing | -$728.8M | -$889.7M | -$1.1B | -$108.7M | -$90.6M | |
| Free Cash Flow | $4.5B | $6B | $6.6B | $1.4B | $1.9B | |
HVRRY
Sector
Market Cap
$30.1B
$687.9M
Price % of 52-Week High
85.8%
87.49%
Dividend Yield
2.6%
2.21%
Shareholder Yield
--
3.86%
1-Year Price Total Return
4.25%
7.14%
Beta (5-Year)
0.734
0.739
Dividend yield:
2.6%
Annualized payout:
$1.10
Payout ratio:
34.06%
Growth streak:
2 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$42.30
200-day SMA
Sell
Level
$43.43
Bollinger Bands (100)
Sell
Level
42.91 - 46.87
Chaikin Money Flow
Sell
Level
-2M
20-day SMA
Sell
Level
$43.53
Relative Strength Index (RSI14)
Sell
Level
32.77
ADX Line
Sell
Level
15.13
Williams %R
Buy
Level
-98.5014
50-day SMA
Sell
Level
$43.46
MACD (12, 26)
Sell
Level
-0.52
25-day Aroon Oscillator
Sell
Level
-64
On Balance Volume
Neutral
Level
3.6M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.574)
Sell
CA Score
(Annual)
Level (-1.9347)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (7)
Buy
Ohlson Score
Level (-0.6642)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Hannover Re is a reinsurance company headquartered in Hannover, Germany. Its roots go back to the 1920s when, in conjunction with the Gerling Group, Haftpflichtverband founded Eisen- und Stahl-Industrie to provide reinsurance services. In the 1960s ownership of the business was turned over to Haftpflichtverband, and Aktiengesellschaft für Transport und- Rückversicherung was founded. This was the basis of Hannover Re. The business expanded into life and health reinsurance in the 1990s, and over the next 30 years expanded beyond its core domestic market of Germany to write business internationally. Hannover sold its commercial specialty insurance business to Talanx in January 2019. Hannover was listed in the 1990s on the Frankfurt Stock Exchange.
Stock Forecast FAQ
In the current month, HVRRY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The HVRRY average analyst price target in the past 3 months is --.
-
Where Will Hannover Rueck SE Stock Be In 1 Year?
According to analysts, the consensus estimate is that Hannover Rueck SE share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Hannover Rueck SE?
Analysts are divided on their view about Hannover Rueck SE share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Hannover Rueck SE is a Sell and believe this share price will rise from its current level to --.
-
What Is Hannover Rueck SE's Price Target?
The price target for Hannover Rueck SE over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is HVRRY A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Hannover Rueck SE is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of HVRRY?
You can purchase shares of Hannover Rueck SE via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Hannover Rueck SE shares.
-
What Is The Hannover Rueck SE Share Price Today?
Hannover Rueck SE was last trading at $42.20 per share. This represents the most recent stock quote for Hannover Rueck SE. Yesterday, Hannover Rueck SE closed at $41.55 per share.
-
How To Buy Hannover Rueck SE Stock Online?
In order to purchase Hannover Rueck SE stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Broadcom vs American Express: Which Is Best?
Chip giant Broadcom Inc. (NASDAQ:AVGO) and card company American Express…
Why Is Adobe Stock Dropping?
Why is Adobe stock dropping? A combination of underwhelming fiscal…
Stock Ideas
Buy
58
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 41x
Buy
51
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Sell
48
Is MSFT Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 36x
Alerts
Sell
25
DRUG alert for Jan 2
Bright Minds Biosciences [DRUG] is up 13.55% over the past day.
Buy
56
QMCO alert for Jan 2
Quantum [QMCO] is up 0.83% over the past day.
Buy
78
BMA alert for Jan 2
Banco Macro SA [BMA] is up 12.94% over the past day.
